CRISPR Therapeutics AG — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Klein Lawrence Otto | CBO & COO | Option Exercise | 16,334 | $14.43 | $235,700 | 26,942 | Jan 15, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 1,304 | $217.44 | $283,542 | 182,989 | Jan 15, 2021 |
| Klein Lawrence Otto | CBO & COO | Sale | 701 | $218.54 | $153,197 | 20,002 | Jan 15, 2021 |
| Klein Lawrence Otto | CBO & COO | Tax Withholding | 9,392 | $153.11 | $1,438,009 | 10,608 | Jan 2, 2021 |
| Kulkarni Samarth | Chief Executive Officer | Option Exercise | 13,800 | $1.81 | $24,978 | 182,989 | Dec 29, 2020 |
| Ho Tony W | Executive VP, Head of R&D | Sale | 500 | $152.41 | $76,205 | 51,715 | Dec 21, 2020 |
| Bolzon Bradley J PhD | — | Sale | 2,576 | $148.28 | $381,969 | 343,732 | Dec 16, 2020 |
| Bolzon Bradley J PhD | — | Sale | 2,223 | $143.26 | $318,467 | 23,548 | Dec 10, 2020 |
| Bolzon Bradley J PhD | — | Sale | 15,900 | $144.85 | $2,303,115 | 314,186 | Dec 10, 2020 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 6,766 | $142.75 | $965,847 | 171,889 | Dec 10, 2020 |
| KASINGER JAMES R. | General Counsel and Secretary | Option Exercise | 22,026 | $13.62 | $299,994 | 22,415 | Dec 9, 2020 |
| Bolzon Bradley J PhD | — | Sale | 4,809 | $144.39 | $694,372 | 513,381 | Dec 7, 2020 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 779 | $129.58 | $100,943 | 169,189 | Dec 1, 2020 |
| Novak Rodger | President | Option Exercise | 50,000 | $14.43 | $721,500 | 698,007 | Nov 30, 2020 |
| Bolzon Bradley J PhD | — | Other | 105,681 | — | — | — | Oct 29, 2020 |
| Novak Rodger | President | Sale | 2,762 | $100.00 | $276,200 | 648,007 | Oct 9, 2020 |
| Bolzon Bradley J PhD | — | Other | 14,780 | — | — | 22,171 | Sep 22, 2020 |
| Bolzon Bradley J PhD | — | Sale | 3,035 | $86.87 | $263,650 | 518,190 | Sep 18, 2020 |
| Bolzon Bradley J PhD | — | Sale | 8,965 | $86.98 | $779,776 | 521,225 | Sep 16, 2020 |
| Bolzon Bradley J PhD | — | Sale | 1,155 | $84.89 | $98,048 | 530,190 | Sep 14, 2020 |
| Bolzon Bradley J PhD | — | Sale | 8,684 | $85.90 | $745,956 | 531,345 | Sep 9, 2020 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 779 | $94.15 | $73,343 | 169,968 | Sep 2, 2020 |
| Bolzon Bradley J PhD | — | Option Exercise | 15,000 | $13.62 | $204,300 | 45,000 | Sep 1, 2020 |
| TOMSICEK MICHAEL JOHN | Chief Financial Officer | Sale | 6,400 | $92.23 | $590,272 | 3,210 | Sep 1, 2020 |
| Novak Rodger | President | Sale | 19,754 | $92.59 | $1,829,023 | 651,847 | Sep 1, 2020 |
| Novak Rodger | President | Sale | 25,000 | $100.00 | $2,500,000 | 648,007 | Aug 19, 2020 |
| Behbahani Ali | — | Other | 14 | — | — | 14 | Aug 13, 2020 |
| TOMSICEK MICHAEL JOHN | Chief Financial Officer | Sale | 6,552 | $86.25 | $565,110 | 5,858 | Aug 3, 2020 |
| Novak Rodger | President | Option Exercise | 19,414 | $14.00 | $271,796 | 673,007 | Jul 7, 2020 |
| Bolzon Bradley J PhD | — | Sale | 5,311 | $83.00 | $440,813 | 554,190 | Jul 6, 2020 |
| Novak Rodger | President | Sale | 50,000 | $80.00 | $4,000,000 | 648,007 | Jul 1, 2020 |
| Klein Lawrence Otto | CBO & COO | Sale | 2,913 | $76.26 | $222,145 | 20,000 | Jun 24, 2020 |
| Novak Rodger | President | Sale | 50,000 | $75.00 | $3,750,000 | 698,007 | Jun 23, 2020 |
| Bolzon Bradley J PhD | — | Sale | 10,000 | $72.51 | $725,100 | 584,190 | Jun 23, 2020 |
| Ho Tony W | Executive VP, Head of R&D | Sale | 229 | $70.14 | $16,062 | 40,676 | Jun 23, 2020 |
| Kulkarni Samarth | Chief Executive Officer | Option Exercise | 17,275 | $1.81 | $31,268 | 188,801 | Jun 1, 2020 |
| Ho Tony W | Executive VP, Head of R&D | Sale | 600 | $70.05 | $42,030 | 47,005 | May 26, 2020 |
| Novak Rodger | President | Sale | 13,384 | $70.01 | $937,014 | 784,623 | May 26, 2020 |
| Kulkarni Samarth | Chief Executive Officer | Sale | 10,693 | $65.28 | $698,039 | 171,526 | May 20, 2020 |
| Novak Rodger | President | Sale | 50,000 | $65.00 | $3,250,000 | 798,007 | May 19, 2020 |
| Klein Lawrence Otto | CBO & COO | Sale | 682 | $61.07 | $41,650 | 20,000 | May 11, 2020 |
| Ho Tony W | Executive VP, Head of R&D | Tax Withholding | 1,563 | $52.64 | $82,276 | 47,605 | Mar 5, 2020 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 794 | $52.74 | $41,876 | 171,526 | Mar 2, 2020 |
| Kulkarni Samarth | Chief Executive Officer | Option Exercise | 8,000 | $1.81 | $14,480 | 172,320 | Dec 16, 2019 |
| Kulkarni Samarth | Chief Executive Officer | Tax Withholding | 741 | $71.65 | $53,093 | 164,320 | Dec 1, 2019 |
| Bolzon Bradley J PhD | — | Sale | 13,745 | $67.41 | $926,550 | — | Nov 19, 2019 |
| Novak Rodger | President | Option Exercise | 33,618 | $14.43 | $485,108 | 33,618 | Nov 19, 2019 |
| CAGNONI PABLO J | — | Sale | 7,500 | $62.00 | $465,000 | — | Nov 19, 2019 |
| CAGNONI PABLO J | — | Sale | 7,500 | $55.00 | $412,500 | — | Nov 12, 2019 |
| CAGNONI PABLO J | — | Sale | 7,500 | $52.00 | $390,000 | — | Oct 30, 2019 |